2/3
The study analyzed 52,297 cases of Omicron and 16,982 cases of Delta within the Kaiser Permanente Southern California healthcare system from November 30, 2021, to January 1, 2022, using S gene target failure (SGTF) as assessed by the ThermoFisher TaqPath ComboKit assay as a
NEW: Study on the severity of those infected with the Omicron Variant compared to the Delta Variant:
⬇️53% less risk of symptomatic hospitalization
⬇️74% less risk of ICU admission
⬇️91% less risk of death
0️⃣Omicron patients required mechanical ventilation
1/2